Expert Opinion on Emerging Drugs
Volume 29, 2024 - Issue 1
Open access
401
Views
0
CrossRef citations to date
0
Altmetric
Review
Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention
Lanfranco Pellesia Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0003-4137-5039View further author information
Messoud Ashinab Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
& Paolo Martellettic School of Health Sciences, Unitelma Sapienza University of Rome, Rome, Italy
https://orcid.org/0000-0002-6556-4128View further author information
Pages 57-64
|
Received 13 Jan 2024, Accepted 08 Feb 2024, Published online: 12 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.